Stay updated with breaking news from Karin Eastham. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Veracyte, Inc. (NASDAQ:VCYT – Get Free Report) Director Karin Eastham sold 2,500 shares of the stock in a transaction that occurred on Friday, June 7th. The shares were sold at an average price of $20.97, for a total transaction of $52,425.00. Following the completion of the transaction, the director now directly owns 33,125 shares of […]
Veracyte, Inc. (NASDAQ:VCYT – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the five brokerages that are presently covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation and four have given a buy recommendation to the company. The average twelve-month price target […]
Shares of Veracyte, Inc. (NASDAQ:VCYT – Get Free Report) have been given a consensus rating of “Moderate Buy” by the five analysts that are covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation and four have given a buy recommendation to the company. The average 12 […]
Veracyte (NASDAQ:VCYT – Get Free Report) is scheduled to issue its quarterly earnings data after the market closes on Tuesday, May 7th. Analysts expect the company to announce earnings of ($0.19) per share for the quarter. Parties interested in participating in the company’s conference call can do so using this link. Veracyte (NASDAQ:VCYT – Get […]
Sumitomo Mitsui Trust Holdings Inc. cut its stake in Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 2.2% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 3,104,676 shares of the biotechnology company’s stock after selling 68,900 shares during the period. Sumitomo Mitsui Trust Holdings Inc. owned about […]